Red blood cell metabolic pathways for ATP synthesis

Red blood cell (RBC) metabolic pathways for ATP synthesis are the biochemical processes by which erythrocytes generate energy in the absence of mitochondria and a nucleus (Frontiers in Physiology, https://www.frontiersin.org/articles/10.3389/fphys.2021.714870/full). The primary pathway is anaerobic glycolysis, also known as the Embden-Meyerhof pathway, which converts glucose into lactate while producing a net gain of two ATP molecules per glucose molecule (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378143/). This ATP is essential for maintaining the RBC's structural integrity, ion gradients via the Na+/K+-ATPase pump, and overall cellular deformability (MDPI, https://www.mdpi.com/2073-4409/12/14/1851). A significant regulatory branch, the Rapoport-Luebering shunt, produces 2,3-bisphosphoglycerate (2,3-BPG), which modulates hemoglobin's affinity for oxygen (Frontiers in Physiology, https://www.frontiersin.org/articles/10.3389/fphys.2021.714870/full). Dysregulation or genetic deficiencies in these pathways, such as pyruvate kinase deficiency, lead to ATP depletion, premature RBC destruction, and chronic hemolytic anemia (Human Metabolome Database, https://humanmetabolome.com/metabolites/HMDB0000124). Modern therapeutic interventions, such as the pyruvate kinase activator mitapivat, target specific enzymes within these pathways to enhance ATP production and improve clinical outcomes in hematologic disorders like sickle cell disease and thalassemia (Frontiers in Physiology, https://www.frontiersin.org/articles/10.3389/fphys.2021.714870/full). These drugs work by allosterically activating the enzyme, thereby increasing the glycolytic flux and restoring energy levels within the cell. Monitoring efficacy typically involves measuring RBC ATP levels, 2,3-BPG concentrations, and markers of hemolysis like reticulocyte count and indirect bilirubin. Safety concerns include potential withdrawal hemolysis if treatment is interrupted and off-target effects related to the specific drug's chemical profile.

Other names

Embden-Meyerhof pathwayAnaerobic glycolysis in erythrocytesRBC energy metabolismErythrocyte ATP synthesis

Allosteric activation of pyruvate kinase, restoration of ATP levels, and modulation of 2,3-bisphosphoglycerate (2,3-BPG) concentrations.